The world of healthcare is abuzz with a groundbreaking report that shines a spotlight on an often-overlooked aspect of women's health. This new study, published in The Lancet Haematology, is a call to action, highlighting the urgent need for improved diagnosis and care for women and girls with hematological conditions.
Unveiling the Report
Led by Dr. Bethany Samuelson Bannow, a hematologist at Cleveland Clinic, the report presents a comprehensive overview of the challenges faced by women and girls with bleeding disorders, heavy menstrual bleeding, postpartum hemorrhage, and other hematological complications. The findings were presented at the International Society on Thrombosis and Haemostasis (ISTH) 2026 Congress in Paris, France, emphasizing the global impact of these issues.
A Critical Gap in Women's Health
Dr. Samuelson Bannow emphasizes that improving hematological care for women is a clear opportunity to enhance health outcomes worldwide. The report underscores a significant gap in women's health, with women facing higher rates of anemia, delayed diagnosis, and undertreatment compared to men. This gap is particularly evident in bleeding and clotting disorders, which often go unrecognized or untreated, especially during menstruation, pregnancy, and the postpartum period.
Delayed Diagnosis: A Shocking Reality
One of the most striking revelations in the report is the delay in diagnosing bleeding disorders. Women, on average, wait a staggering 14 to 16 years for a diagnosis, compared to just two years for men. This delay is a major concern, as it can lead to severe complications and a lower quality of life. The report calls for urgent action to reduce this gap and ensure timely diagnosis and treatment.
Heavy Menstrual Bleeding: A Central Issue
Heavy menstrual bleeding, affecting up to one-third of women, is often the first sign of an inherited bleeding disorder. However, it is frequently dismissed or inadequately addressed. The authors emphasize the need for routine menstrual health assessments, broader use of bleeding assessment tools, and improved referral pathways to ensure earlier recognition and care.
Ambitious Goals for the Future
The commission sets an ambitious yet achievable goal: to reduce the average time from symptom onset to diagnosis for women and girls with bleeding disorders to less than 24 months by 2035. This target is a powerful motivator, pushing for faster and more efficient diagnosis and care.
A Milestone for Women's Health
ISTH President Pantep Angchaisuksiri recognizes the publication of this commission as a significant milestone. Women face unique challenges related to bleeding and clotting disorders, yet these issues often remain underrecognized and understudied. This report provides a much-needed resource for clinicians, researchers, policymakers, and advocates to improve outcomes globally.
Closing Gender Gaps in Hematological Health
The report calls for immediate action to address gender disparities in hematological health. Key recommendations include faster diagnosis of bleeding disorders, universal screening for heavy menstrual bleeding and iron deficiency, standardized postpartum hemorrhage protocols, and personalized thrombosis care during pregnancy and the postpartum period. The authors also emphasize the need for updated clinical guidelines, increased inclusion of women in research, targeted education, and greater investment in women's health.
A Clear Path Forward
Dr. Samuelson Bannow believes that meaningful progress is possible. With coordinated efforts across clinical care, research, and education, we can deliver more timely, effective, and equitable hematology care for women and girls worldwide. This report is a powerful step towards achieving that goal, offering a roadmap for a healthier future for women.
Final Thoughts
This report is a wake-up call, reminding us of the critical importance of addressing gender disparities in healthcare. By recognizing and acting upon these issues, we can ensure that women receive the timely and effective care they deserve, improving health outcomes and quality of life.
